Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Heron Therapeutics Inc HRTX

Healthcare Biotechnology
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and... see more

Recent & Breaking News (NDAQ:HRTX)

HERON THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for Southern District of California against Heron Therapeutics, Inc.

GlobeNewswire June 10, 2019

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Press Releases June 10, 2019

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Heron Therapeutics, Inc. Investors

Business Wire June 7, 2019

CLASS ACTION UPDATE for CBL, AOS and HRTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases June 7, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX

Press Releases June 7, 2019

CLASS ACTION UPDATE for BE, CBL and HRTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases June 7, 2019

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Press Releases June 7, 2019

Robbins Arroyo LLP: Heron Therapeutics, Inc. (HRTX) Misled Shareholders According to a Recently Filed Lawsuit

Business Wire June 7, 2019

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JMIA, CYH and HRTX

Press Releases June 7, 2019

(HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019

Press Releases June 7, 2019

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CBL, CYH and HRTX

Press Releases June 6, 2019

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Heron Therapeutics, Inc. Investors (HRTX)

Business Wire June 6, 2019

CLASS ACTION UPDATE for BE, HL and HRTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases June 6, 2019

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Heron Therapeutics, Inc. Investors (HRTX)

Business Wire June 5, 2019

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Heron Therapeutics, Inc. Investors (HRTX)

Business Wire June 5, 2019

HRTX REMINDER: ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important Deadline in the Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - HRTX

Business Wire June 5, 2019

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Press Releases June 5, 2019

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MWA, CBL and HRTX

Press Releases June 5, 2019

Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: August 5, 2019

GlobeNewswire June 5, 2019

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BA, MWA and HRTX

Press Releases June 5, 2019